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Acute murine lymphocytic choriomeningitis (LCM) ~ is  a  well documented 
example of predominantly cell-mediated immunopathology. The experimental 
evidence leading to this conclusion has been reviewed in extenso recently (1-3). 
The pathological process in vivo can be monitored in vitro by measuring LCM 
virus (LCMV)-specific cytotoxic activity of  thymus-derived  lymphocytes (T cells) 
for LCMV-infected target cells (4-7). That these cytotoxic  T cells may be directly 
involved in destroying the meninges and ependymal cells is suggested by the 
fact that they can be isolated with great specific reactivity from cerebrospinal 
fluid of clinically affected mice (8). 
Oldstene et al. (9) reported that a small but statistically significant suscepti- 
bility difference of two mouse strains could be linked to their H-2 type, possibly 
reflecting  Ir gene control. More recently, with the mouse strains available now, 
this difference no longer appears to be statistically significant (10). Neverthe- 
less,  it was during the attempt to correlate increased susceptibility to acute 
LCM with the capacity of various mouse strains to generate LCMV-specific  T 
cells with greater cytotoxic activity and quicker than less susceptible mice that 
the unexpected  H-2 restriction of cytolytic activity was originally found (2, 11). 
Many other T-cell functions were known or were subsequently shown to be 
restricted by the H-2  gene complex in a  similar or different way. For the T- 
helper function, T cells and bone marrow-derived lymphocytes (B cells) clearly 
require compatibility at the I  but not at the K  or D  region of H-2  (12, 13). 
* This is publication no.  1055 from the Department of Immunopathology, Scripps Clinic and 
Research Foundation. Part of this research was supported by U. S. Public Health Service grants 
AI-07007 and AI-I2734. 
1  Abbreviations used in this paper: J774,  BALB/c fibrosarcoma cells;  L cells, L929 C3H fibro- 
blasts;  LCM,  lymphocytic choriomeningitis; LCMV,  lymphocytic choriomeningitis virus; LD~o, 
lethal dose for 50% of recipients; LU, lytic unit; P815, DBA/2 mastocytoma cells; PFU, plaque- 
forming units. 
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Exceptions to this rule were subsequently found by experiments using alloanti- 
gen-tolerant T  cells  (14,  15). Also,  effector T  cells involved in  delayed type 
hypersensitivity to  fowl  7-globulin  must  be/-region  compatible  for  optimal 
expression of  function (16). Quite different, LCMV, pox-, or Sendai virus-specific 
cytolytic interactions require K- or D-region compatibility (17-19).  In an earlier 
report it was shown that/-region compatibility alone was not or only questiona- 
bly sufficient for lysis to occur (17). However, it is not known whether the target 
cells used in these studies express any cell surface structure coded by the H-2I 
region, such as Ia antigens. 
The role of structures coded by the/-region genes for expression of cytolytic 
effector function was therefore reassessed using macrophage target cells, which 
are  known  to  possess Ia  cell  surface specificities  (20-22).  Furthermore,  the 
regulating  role  of/-region  genes  on  the  capacity  to  generate  virus-specific 
cytotoxic T  cells in vivo was investigated. No obvious role for a  structural or 
regulatory/-region gene product could be detected. However, the results indi- 
cate that non-H-2  genes may greatly influence immune responsiveness mea- 
sured by virus-specific cytotoxicity. 
Materials and Methods 
Mice.  6- to 9-wk-old CBAJH, C57BL/6, BALB/c, BALB/c × C57BL/6 F1, and DBA/2 were either 
bred in the colonies maintained at the Australian National University (Tables II-IV) or were 
purchased  from The Jackson  Laboratory,  Bar  Harbor,  Maine  (Tables  V-VII).  SJL/J,  DBA/1, 
B10.D2,  B10.A, B10.A(2r), B10.A(4r), B10.A(5r), and C57BL/10 were from The Jackson Labora- 
tory. A.TFR3, A.TFR5, A.TL, A.TH, C3H.OH, C3H.OL, D2.GD, and DA/HuSn were from colonies 
originating from the Department of Human Genetics, University of Michigan Medical School. The 
H-2 haplotypes of the mice used are summarized in Table I  (22). 
Virus and Immunization.  Both the immunization procedures (6,  7, 17,  19) and the strains of 
LCMV (6,  7,  17) of ectromelia virus (17) and the vaccinia virus used (18) have been described in 
detail  elsewhere.  Mice  were,  unless  otherwise  stated,  injected  intravenously  (i.v.)  with  103 
intracerebral (i.c.) LDso (lethal dose for 50% of recipients) of the WE strain of LCMV or 2-5 ×  104 
plaque forming units (PFU) of a  virulent Hampsted egg ectromelia virus or 2  ×  l0  T PFU of WR 
vaccinia virus. The vaccinia virus was a gift of Dr. W. K. Joklik, Duke University, Durham, N. C. 
LCMV immune spleen cells were usually harvested at 7 days, pox virus immune spleen cells at 6 
days after infection. 
5'Cr Release  Assay.  The techniques employed and the cell lines used as targets have been 
described (4-6, 7, 19, 24-28). Peritoneal macrophages either from unstimulated mice (11) or from 
mice injected 4 days previously with thioglycollate were plated into flat bottom 96-well hemagglu- 
tination trays (Falcon Plastics, Oxnard, Calif.) at 2 ×  105 cells/well. The following day monolayers 
were infected with LCMV for 24 h  or with pox viruses for 6 h  and labeled with 5~Cr. Immune or 
normal spleen cells were overlaid usually at a ratio of 30 to 1 target cell and incubated at 37°C. 51Cr 
release was determined 5-14 h  later.  Release by water represents 100% release; results are not 
corrected for spontaneous 5'Cr release. Means -+ SEM of triplicates were determined and compared 
by using Student's t test. 
Results 
Genetic Mapping  with Macrophage  Targets.  Reciprocal assays were done 
using immune spleen cells and virus-infected macrophages from H-2 recombi- 
nant and original type mouse strains (Tables I and II). Significant lysis by virus 
immune spleen cells on infected targets,  as compared with immune cells on 
uninfected or normal cells on infected targets, was recognized when donors of ZINKERNAGEL,  DUNLOP,  BLANDEN,  DOHERTY,  AND  SHREFFLER 
TABLE  I 
H-2 Haplotypes of the Mice  Used* 
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* From Shreffler and David (23). 
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virus immune spleen cells and infected macrophage targets were compatible at 
the K  or D  regions of the H-2 gene complex. K-region compatibility alone, as for 
A.TL on SJL, was sufficient, as was D-region homology alone.  (A.TL --* BALB/ 
c, CBA/H --* C3H.OH, BALB/c --* A.TH, Tables II and VIII). Cytolysis was not 
observed when donors of T cells and targets shared identity only in the I  region, 
as for A.TL --* CBA/H, and BALB/c --* B10.A(2r) which are compatible at the/- 
C  and S  regions. 
Effect of Various H-2I-Region Specificities on the Generation and Expression 
of Virus-Specific Cytotoxicity Associated with H-2D'(  The possible role for I- 
region  genes  in  the  generation  in vivo of virus-specific cytotoxic T  cells was 
investigated  using  H-2  recombinant  mice.  Several H-2  recombinant  mouse 
strains derived from the A strain share the D ~ allele, but possess different I and 
K  regions of other than H-2 d origin. The virus-specific cytotoxic activity gener- 
ated  in  vivo was assessed in  vitro  by determining  lyric units  (LU),  i.e.,  the 
average number of spleen cells necessary to lyse 1/3 of a  standard  number of 
target cells (23). The smaller the value, the relatively more active is the tested 
spleen cell population. 
The  LU  generated  during  LCMV  infection  in  the  various  mouse  strains 
differed maximally by a factor of 1.7, while the comparable value for ectromelia 
was  2.5  (Table III).  These  variations  do not seem to reflect specific non-H-2 
differences as mice of both the A strain and B10 non-H-2 background show the 
spectrum of activities with both virus infections. 
Relative  cytotoxic activity  of BALB/c  immune  spleen  cells  on H-2 d virus- 
infected target cells tended to be low, even though the whole of the H-2 gene 522  REGULATION  OF  IMMUNE  RESPONSE  TO  VIRUS 
TABLE II 
I-Region Compatibility is Neither Sufficient Nor Necessary for Virus-Specific Cytolysis 
of Macrophage Targets 
Immunc-  Mouse  Target infec- 
gen*  strain  tion 
Percent  ~lCr release  from macrephages$ 
SJL/J  C BA/H  BALB/c 
Ectromelia 
virus 
LCMV 
A.TL  Ectromelia  53.1  _+  3.1§  23.5  ±  0.7  62.7  -+  2.~1 
CBA/H  Ectromelia  18.5 ±  0.8  57.6  ±  3.~1  32.8  ±  3.:~1 
A.TL  Nil  25.2  ±  1.1  24.7  ±  0.4  21.9  ±  1.3 
CBA/H  Nil  25.4 -+  2.3  20.3  ±  0.6  19.9 +_ 2.5 
A.TL  LCMV  45.1  -+  1.8~1  28.7  ±  1.0  68.3  ±  1.:~[ 
CBAIH  LCMV  29.8 _+  1.2  62.6  ±  3.~1  26.5 -+ 0.8 
A/J  LCMV  26.6 ±  0.8  51.7  -~  1.:~1  68.6  ±  1.$1 
Normal  LCMV  28.5  ±  0.2  23.3  ±  0.4  30.5  -+  1.4 
CBA/H 
Ectromelia 
virus 
LCMV 
C3H.OH  B10.A(2r)  DA/HuSn  A.TH  A.TL 
BALB/c  Ectromelia¶  52.2  *_ 2.1  H  46.6  -~ 3.1  44.7  ±  4.2  46,9  ±  2.~[  NT 
CBA/H  Ectromelia  45.3  ±  3.4~1  72,1  ±  4.7~1  40.3  -+  0.8  35,0  -+  1,3  NT 
SJL/J  Ectromelia  40.4 _+  2.8  51.2  ~  3.2  65.3  -+  1.~1  63.0  -+  2.~1  NT 
C57BL/6J  Ectromelia  38.9 ±  2.5  67.9  -+  2.~1  46.8  ±  1.7  37,4  ±  1.1  NT 
DBA/1  Ectromelia  38.7  ±  2.5  47.2  ±  4.0  70.1  ±  4.1ll  41,5  ±  4,5  NT 
Nil  Ectremelia  33.4 ±  1.0  51.1  +- 4.2  39.7  ±  1.5  35,3  ±  1.3  NT 
BALB/e  LCMV  82.8  ±  4.~1  52.3  ~  5.0  40.1  -+  7.1  90.4  _+  5.~1  87.6  _+ 8.@1 
CBA/H  LCMV  96.4  ±  7.~[  78.4  ±  3.2~1  42.9  -+  8.4  60.1  ±  5.1  58.8 _+  1.5 
C57BL/6  LCMV  NT**  70.3  ±  4.~1  42.7  ±  9.6  66.7  ±  5.8  NT 
DBA/1  LCMV  NT  NT  50.6  -+ 3.@[  57.8 ±  6.3  NT 
SJL/J  LCMV  57.1  -+  5.1  54.9  ±  8.4  60.0  -~ 5.~I  83.8  ±  6.i[I  68.2  ±  2.41 
Normal  LCMV  50.9 -+  10.1  48.7  ±  3.8  40.5  -+ 2.5  66.6  ±  7.0  55.4  _+ 4.8 
C57BL/6 
* Mice were infected i.v. with 2  ×  104 PFU  attenuated  ectroraelia virus or 2  ×  103 i.c. LDso of WE3 LCMV, and spleen cells were 
harvested  respectively  6 or 7 days later. 
* Immune  or normal spleen cells were assayed  at a  spleen cell to target ratio of 30:1 for 10 h  at 3TC. 
§ Means  _+  SEM  of triplicates.  Release  by  immune  spleen  cells  on  infected  targets  was  recorded  as  significant  only  when 
statistically  greater than release caused on uninfected  targets or of normal spleen cells on normal or infected targets. 
I] Significantly different from controls  (P  <  0.05). 
¶  S~Cr release of immune  spleen cells on uninfected target cells varied from 29.7 to 36.5 on C3H.OH, from 30.1 to 46.7 on A.TH, 
from 27.7 to 35.6 on B10.A(2r),  and from 32.9 to 41.4 on DA/HuSn  targets. 
** NT, not tested. 
complex is shared.  Thus,  there  was no indication  that/-region  compatibility 
conferred enhanced  cytolytic capacity,  especially as,  in this  case,  donors of T 
cells and target  cells are  also compatible at H-2K d.  When the total cytotoxic 
activity per spleen was calculated for LCMV-infected mice, differences up to 6.5- 
fold were noticed between strains,  e.g., A.TL and B10.A. Most of these differ- 
ences are,  however, explained mainly by the differences in mean total spleen 
cell numbers. 
Low  Responsiveness  of D2.GD  Mice  to  LCMV.  When  a  number  of H-2 
recombinant mouse strains were assayed for LCMV-specific cytotoxicity, D2.GD 
(H-2KdD b)  mice  were  found  to  have  little,  if any,  activity  against  LCMV- 
infected H-2 d targets. Further experiments revealed that D2.GD 7-day immune 
spleen cells were not active at 30:1 against H-2K ~ compatible targets  (C3H.OL 
or BALB/c macrophages),  but were lytic for H-2D b compatible targets  (Table 
IV).  Although  it  appeared  from  these  results  that  D2.GD  cells  might  not 
efficiently  express  antigen-associated  with  H-2K d,  it  became  obvious,  in  a 
second experiment,  that they were comparable to other K d targets  (Table V). ZINKERNAGEL,  DUNLOP,  BLANDEN,  DOHERTY~  AND  SHREFFLER  523 
TABLE III 
Cytotoxic Activity of Virus Immune T Cells of Various I-Region Specificities for H-2D  d 
Compatible Virus-Infected Mastocytoma P815 (H-2 d) Target Cells 
LCMV* 
Exp.  1  Exp.  2  Ectromelia* 
Mouse strain  H-2 haplotype  LU  (1@) 
LU$  Spleen  LU/  LU 
(10.~)  cells per  spleen  (l&~) 
spleen (107  )  (102  ) 
A.TFR3  f  fff  s  d  1.4  3.0  2.2  2.7  1.7 
A.TFR5  f  fff  k  d  1.5  9.0  6.0  2.5  NT 
A.TH  s  sss  s  d  2.2  7.0  3.2  3.5  3.4 
A.TL  s  kkk k  d  2.4  2.2  0.7  4.0  4.0 
B10.A  k  kkdd  d  1.5  9.0  6.0  2.5  3.1 
B10.A(5r)  b  bbd d  d  2.2  8.5  3.9  3.5  1.6 
BALB/c  d  dddd d  2.1  12.0  5.7  NT  NT 
*  Spleen cells from mice infected for 7 days with 2  ×  10  s i.c. LDs~ of WE3 LCMV or for 6 days with 2 
×  104  PFU  ectromelia  virus  were  assayed  at  various  ratios  (30:1-1:1)  on  virus-infected  P815 
target  cells. 
Mean  number  of immune  spleen cells needed to specifically release 33% of the TM Cr incorporated 
by 5  ×  104 target  cells (24). 
TABLE  IV 
Differential Capacity of H-2K  'r Compatible D2.GD and C3H.OL Mice to Generate 
Cytotoxic  T Cells in LCM Infection 
Spleen  cells 
i  *  Percent :'  Cr release from LCMV-infected macrophages 
D2.GD  C3H.OL  BALB/c  C57BL  CBA/H 
lmmune$  D2.GD  43.6 ± 1.4§  28.3 ± 2.1  29.2 ± 1.111  43.5 ± 1.85  22.3 ± 0.6 
Normal  D2.GD  23.5 ± 0.8  24.9 ± 1.6  26.1 ± 1.5  25.0 ± 1.7  22.9 ± 0.6 
Immune  C3H.OL  26.2 ± 1.5  43.5 ± 2.35  38.8 ± 2.~[}  NT  30.5 ± 0.4} 
Normal  C3H.OL  24.1 ± 0.4  24.7 ±  1.8  26.8 ± 0.9  NT  19.9 ± 0.7 
Immune  BALB/c  38.7 ± 0.5}  NT  61.7 ± 2.4§  31.7 ±  1.2  NT 
Normal  BALB/c  34.2 ± 0.5  NT  27.3 ± 2.0  33.2 ± 1.1  NT 
Immune  BALB/e x  60.0 ±  1.7}  36.1 ± 2.5  74.8 ± 1.1}  70.2 ± 1.1§  28.2 ± 1.0 
C57BL F, 
* Spleen cell to target ratio 30:1, incubated for 7 h at 3TC. 
$ Mice were infected with 2 × 10  s i.c. LDso  of WE3 LCMV 7 days previously. 
II When immune  spleen cells from four individual D2.GD immune  mice were assayed on LCMV-infected DBA]2 (P815) m~tocytoma 
cells, levels of~'Cr release ranged from 21.8 ± 0.8 to 23.5 ± 0.8 compared with 35.0 ± 1.6 to 39.3 ± 1.3 for C3H.OL immune  T cells. 
Values for normal spleen cells were 20.4 -* 0.7 and 18.2 ± 0.9, respectively. 
} Significantly  different from immune spleen cells on uninfected  targets and/or normal spleen cells on infected targets. 
This low responsiveness under the conditions tested was specific for LCMV, as 
pox virus infection provoked high cytotoxic activity  (Table V). 
D2.GD  mice  are  derived  from  the  DBA/2  strain  which,  when  assayed  for 
LCMV-specific cytotoxicity, were also found to be low or nonresponders. Individ- 
ual mice were infected with a  standard dose of 103 LDs0 i.c.  and assayed 7 or 9 
days  later.  During this time  interval  maximal  cytotoxic activity  was usually 
observed with all strains tested so far (17, 24) (Table VI). Immune spleen cells 
from DBA/2 and D2.GD mice caused virtually no lysis ofK  d targets, but D2.GD 
cells were lytic for D b target cells although much less lytic than were those from 
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TABLE  V 
Comparison of the Cytotoxic Activity Generated in Various Mouse Strains Infected with 
LCMV or Vaccinia Virus 
Spleen cells 
Percent ~lCr release from LCMV-infected macrophages* 
D2.GD  C3H.OH  BALB/c  C57BL 
LCMV-immune$  D2.GD  NT  37.2  ±  1.4§1[  31.7  ±  1.6  45.3  ±  1.41 
Normal  D2.GD  NT  32.4  ±  1.8  28.6  ±  1.7  29.7  ±  1.5 
LCMV-immune  C3H.OL  NT  NT  55.3  ±  2.(~  I  NT 
LCMV-immune  B10.D2  62.7  ±  1.~1  52.0  ±  1.711  72.7  ±  2.41  34.5  ±  2.4 
Normal  B10.D2  30.5  _  1.3  36.9  ±_  1.4  32.2  ±  1.3  30.6  ±  1.8 
LCMV-immune  BALB/c  56.1  ±  2.111  52.4  +__  1.~1  47.9  ±  1.41  31.1  ±  1.4 
LCMV-immune  C57BL/6  67.1  ±  1.~1  36.5  ~-  1.6  NT  75.0  ±  2.211 
Percent  5'Cr  release  from  vaccinia-virus 
phages¶ 
infected  macro- 
Vaccinia-immune**  D2.GD  NT  88.4  ±  1.8§11  82.9  -+ 2.111  71.3  ±  1.41 
Normal  D2.GD  NT  53.2  ±  3.1  47.5  ±  2.6  43.8  ±  1.4 
Vaccinia-immune  C3H.OL  NT  NT  90.5  ±  1.41  NT 
Vaccinia-immune  B10.D2  NT  84.4  ___ 2.~1  84.8  +  3.~1  48.1  ±  2.0 
Normal  B10.D2  NT  48.8  _+  1.9  48.1  ±  2.4  46.2  -  1.7 
Vaccinia-immune  BALB/c  NT  88.1  _+  2.(~1  96.0  ±  3.~1  NT 
Vaccinia-immune  C57BL/6  NT  NT  NT  101.5  ±  2.4~1 
* Spleen cell:target cell ratio 30:1; incubation time 5 h  at 37°C. 
$ Mice were infected with 2  x  103 i.c. LD50 of WE LCMV 7 days previously. 
§ Means +_ SEM of triplicates. 
II Significantly different from release by normal spleen cells (P <  0.05). 
¶  Tested at 30:1; incubation time 8 h  at 37°C. 
** Mice were infected with 2  ×  107 PFU of WR vaccinia virus 6 days previously. 
Virus Dose-Dependent Low Responsiveness of  DBA/2 Mice is Recessive.  The 
DBA/2 and D2.GD mice generated greatest cytotoxicity at the lowest infectious 
doses of LCMV. However, even under these conditions, BALB/c mice responded 
better than DBA/2 mice (Table VII). The results obtained with the established 
cell line  J774  (H-2 ~)  as target  were more  clear-cut than  those with  C3H.OL 
macrophages.  However, both results indicate that over a  wide range  of infec- 
tious  doses tested  7  days  after  infection,  BALB/c or  C3H  x  DBA/2  F1  mice 
responded with a least 10 times greater activity (Table VII). The low responsive- 
ness is thus virus-dose dependent and recessive. This was further confirmed by 
the result that C3H and C3H x  DBA/2 F, LCMV immune spleen cells were of 
comparable activity for LCMV-infected L cells. 
Discussion 
There  is at present  no conclusive evidence available  for a  role of Ir genes 
which determine susceptibility to virus infections in mice  (10).  The presented 
results  also failed to reveal  a  demonstrable  role for/-region  genes  in  LCMV 
infections as far as generation  of virus-specific cytotoxicity measured in vitro 
goes. 
No LCMV or pox virus-specific cytotoxic activity associated with the I  region 
of H-2 could be detected under the conditions employed./-region compatibility ZINKERNAGEL,  DUNLOP,  BLANDEN,  DOHERTY,  AND  SHREFFLER 
TABLE  VI 
Low Cytolytic Activity Generated by LCMV-Infected DBA Mice 
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Percent S;Cr release from macrophage targets by spleen cells* 
7 day LCMV immune$  9 Day LCMV immune 
Spleen cells 
C3H.OL  B10.A(4r)  C3H.OL  B10.A(4r) 
Unin-  Umn-  Umn-  Umn- 
Infe~  Infe~  Infected  I~e~ 
D2.GD  1§  30.0  ±  2.111  28.7  ±  2.0 
2  33.1  ±  1.7  29.4  ±  1.2 
3  -  - 
DBA]2  1§  27.8 ±  2.1  26.3  ±  2.1 
2  32.9  ±  1.5¶  27.5 ±  1.2 
3  -  - 
B10.D2  1§  48.6  ±  2.0~  28.9  ±  1.7 
2  45.1  ±  1.9~  24.8 -+ 2.3 
3 
C57BIJ10  1§  33.4  -+  1.2  30.3  ±  2.1 
2  30.8  ±  2.1  25.9  ±  2.4 
55.9  ±  2.5¶  34.2  ±  2.1  28.5 ±  1.0  26.7 ±  1.1  30.7  ±  1.2  29.1  ±  1.1 
59.8  ±  2.1¶  32.0  ±  1.3  25.9  ±  0.8  25.0  ±  2.0  33.3  ±  1.4  28.7 ±  0.9 
-  -  30.2  ±  1.2  28.3  ±  1.4  29.0 ±  1.1  28.1  ±  1.4 
30.1  ±  1.1  28.0  ±  1.7  26.2  ±  2.2  29.6  ±  1.1  29.8  ±  1.0  32.1  ±  2.1 
34.6  ±  1.4  31.3  ±  2.2  25.0  ±  2.5  28.0 ±  1.9  28.4 ±  2.1  27.4 ±  1.0 
-  -  22.7  -+  1.1  26.9  ±  0.8  26.6  ±  1.6  25.8 ±  2.7 
31.8  ±  1.4  32.8  ±  1.8  56.8  ±  2.5¶  28.3  ±  1.8  26.8  ±  1.5  25.0 ±  2.1 
34.6  ±  1.6  29.2  ±  1.6  52.0 ±  1.8¶  25.7  ±  2.2  28.5 ±  0.9  26.7  ±  1.1 
-  -  45.1  ±  3.1¶  29.5 ±  1.5  31.5  _+  1.1  28.2 ±  1.0 
93.1  ±  2.8¶  33.2  ±  4.1  31.1  ±  1.0  32.8  ±  2.0  85.4  ±  3.1¶  30.7  ±  2.2 
82.3  ±  3.0~  32.9  ±  2.0  32.0  ±  1.1  31.8  -+ 0.7  79.5 ±  2.8¶  29.1  ±  1.8 
Normal 
D2.GD  28.7  ±  2.1  28.1  ±  1.0  28.6  ±  2.1  26.7  ±  3.2 
DBA/2  27.2  -:- 2.0  30.1  ±  2.1  27.7  ±  1.3  27.0  ±  1.0 
B10.D2  28.9  ±  1.1  28.5  ±  0.8  28.0  ±  1.0  26.1  ±  1.4 
C57BL]10  29.5 ±  2.2  28.1  ±  1.2  26.2  ±  2.4  25.7  ±  1.3 
* Immune  spleen cells were assayed at 30:1 for 4 h  at 3TC. 
$ Mice were infected  i.v.  with 2  ×  103 i.c.  LD~o  7 and 9 days previously: 
§ Individual  mice. 
It Means  ±  SEM of triplicates. 
¶  S'Cr release  significantly greater than  relevant  controls  (P <  0.05). 
alone did not result in any cytotoxicity, nor did it obviously facilitate K- or D- 
region-associated virus-specific activity (summarized in Table VIII). Neverthe- 
less, minor activities could be easily missed because of the greater variability of 
macrophage targets as compared with established cell lines. 
Macrophages have been shown to synthesize and to express (20-22) Ia struc- 
tures  which  are  coded for  in  the I  region.  Macrophages  are  members  of the 
reticuloendothelial system and are probably the first cells to take up free virus 
from the circulation. Although it is not known as yet how and if cytotoxic T cells 
(24-28)  play  any  direct  role  in  controlling  virus  growth  and/or  spreading, 
interaction  (cytolytic  or  noncytolytic  in  vivo)  between  T  cells  and  infected 
macrophages are probably important for this function  (reviewed in 29).  These 
cells may thus  represent biologically relevant targets.  The conclusion that I- 
coded structures appear to be of certainly lesser relevance than K- or D-coded 
structures for virus-specific T-cell effector functions is supported by the finding 
that  the  adoptive  transfer  of both  inflammatory  process  (18)  and  anti-viral 
protection is also dependent upon K  or D, but not/-region compatibility (30).2 
The capacity to generate D~-associated cytotoxicity in vivo was also not under 
2  Zinkernagel,  R.  M.,  and  R.  M.  Welsh.  1976.  H-2 compatibility  requirement  for  virus-specific 
T-cell-mediated  effector  functions  in  vivo.  I.  Specificity  of  T  cells  conferring  antiviral  protection 
against  lymphocytic  choriomeningitis  virus  is  associated  with  H-2I~ and H-2D. J. Immunol.  Sub- 
mitted  for  publication. 526  REGULATION  OF  IMMUNE  RESPONSE  TO  VIRUS 
TABLE VII 
Virus Dose-Dependent Low Responsiveness to LCMV Measured as Cytotoxic Activity is 
Recessive 
Dose of  Percent ~'Cr release from LCMV-infected targets*: ratio immune spleen cells: one target cell 
LCMV 
Spleen cells  J774  C3H.OL  L cells 
log 10 i.c. 
LD~o  30  10  3  30  10  3  30  10 
BALBIc$ 
D2.GD** 
DB~2 
C3H  x  DBA/2 
F, 
C3H 
BALB 
D2,GD 
DBA/2 
C3Hx DBA/2 
F, 
C3H 
Medium 
1  80.6~]  58.41  47.8  58.~1  57.1~  I  50.3  NT~  NT  NT 
2  76.$1  66.41  52.7  58.41  5O.~l  45.4  NT  NT  NT 
3  60.61  52.41  38.9  45.8  49.8  50.5  NT  NT  NT 
4  54.41  50.41  45.6  47.9  42.8  44.9  NT  NT  NT 
1  37.9  37.9  40.7  43.7  45.2  39.5  NT  NT  NT 
2  42.1  38.7  36.7  45.8  45.2  43.8  NT  NT  NT 
3  37.3  39.7  37.1  47.6  48.5  39.8  NT  NT  NT 
4  40.4  41.1  41.1  46.2  44.0  43.4  NT  NT  NT 
1  52.$1  49.6  46.1  61.#~I  55.9  54.1  NT  NT  NT 
2  49.2  50.5  44.5  47.9  52.1  46.8  NT  NT  NT 
3  44.9  44.3  40.0  57.6  48.9  48.8  NT  NT  NT 
4  41.5  35.7  36.2  42.7  42.7  44.6  NT  NT  NT 
1  94.111  77.~1  53.5  7~1  641  51  ST  NT  NT 
2  100.4]  99.111  70.1  841  741  5~1  106.~1  100.41  67.~1 
3  95.'~l  100.~[  69.8  9~1  6~[  641  96.41  9o.~1  59.~l 
4  102.~1  100.111  50.7  6~1  541  41  NT  NT  NT 
1  NT  NT  NT  NT  NT  NT  NT  NT  NT 
2  NT  NT  NT  NT  NT  ST  86.~1  90.4~1  55.~1 
3  NT  NT  NT  NT  NT  NT  90.'~[  91.0~[  60.8~[ 
4  NT  NT  NT  NT  NT  NT  NT  NT  NT 
Normal  43.0  NT  NT  42.1  NT  NT  NT  NT  NT 
Normal  42.2  NT  NT  46.3  NT  NT  NT  NT  NT 
Normal  46.1  NT  NT  47.7  NT  NT  NT  NT  NT 
Normal  48.7  NT  NT  50.8  NT  NT  33.5  NT  NT 
Normal  NT  NT  NT  NT  NT  NT  28.2  NT  NT 
45.6  NT  NT  43.2  NT  NT  26.0  NT  NT 
* Spleen cells  were assayed for 12 h at 3TC. 
Mice were injected  i.v.  with the indicated doses of  LCMV  8 days previously. Results are from spleen cell  pools of 2-3 mice. 
§ Means of triplicates.  SEM  were from 0.5-1.5  for  J774, 1.0-2.8  for C3H.OL, and 0.8-1.5  for L cells. 
I{  Significantly (P < 0.05)  greater than normal spleen cells  on infected  targets or immune ceils  on uninfected targets (data not shown). 
¶ NT, not tested. 
** D2.GD immune spleen cells  from mice infected  with 10 i.c.  LD~o and assayed on infected  C57BI.J6 (H-2  ~)  targets gave lysis  of  55% (30:1), 
54% (10:1),  and 45% (3:1);  only the first  two values being significantly  greater than controls (P < 0.05);  all other doses of  infections  did 
not cause generation of  measurable cytotoxicity. 
marked/-region control. The normal association between I ~ and D d in the H-2 ~ 
haplotype did not confer any greater potential to generate cytotoxicity than the 
other four or five/-region specificities tested in H-2  recombinants. The semi- 
quantitative comparison of relative cytolytic activities did not vary more than a 
factor of 2.5,  and mean activities per spleen were thus dictated mainly by the 
spleen cell numbers. Theoretically, the IC k subregion of  H-2I may have caused a 
lower response for LCMV-infected D d targets as compared with K '~.  Alterna- 
tively, the combination of IA kiCk may generate lower responses than IA ~-IC~; ZINKERNAGEL,  DUNLOP,  BLANDEN,  DOHERTY,  AND  SHREFFLER 
TABLE VIII 
Summary  of the Genetic Analysis 
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Strain combinations tested (immune spleen 
cells-target) 
H-2 region compatibility 
K  1  S  D 
ABC 
Lysis 
CBA/H-CBA/H, BALB/c-BALB/c 
C3H.OL-C3H.OL, D2.GD-D2.GD 
BALB/c-C3H.OH, SJL-A.TH 
DBA/1-DA/HuSn 
DBA/2-C3H.OL, B10.D2-C3H.OL 
C3H.OL-BALB/c 
CBA/H-BI0.A(2r) 
BALB/c-D2.GD, C3H.OL-D2.GD 
D2.GD-C3H.OH, D2.GD-BALB/c 
A.TL-SJL 
A.TL-CBA/H 
BALB/c-B10.A(2r) 
D2.GD-C57BL/6 
C57BL/6-B10.A(4r),  D2.GD-B10.A(4r) 
B10.A-DBA/2,  B10.A(5r)-DBA/2 
C3H.OL-CBA/H 
A.TL-BALB/c, BALB/c-A.TH, CBA/H- 
C3H.OH,  SJL-DA/HuSn,  C57BL/6- 
B10.A(2r), (A.TB,  A.TD, A.TH, A.TL)- 
DBA/2 
+ 
this explanation could be a possibility if a two gene model for Ir gene regulation 
of immune responsiveness is invoked (31,  32). 
The variable,  small differential activity to D °, but not to K d, in D2.GD mice 
could be explained in a similar way. The IA d subregion by itself is not associated 
with  low  response  to  LCMV-altered  K  d,  e.g.,  in  B10.D2  strong  cytotoxicity 
against Kd-infected targets is observed. The combination ofIA d with IB b and/or 
IC b might thus impair generation of cytotoxicity. LCMV-immune B10.A(5r) are 
active for D d targets,  eliminating  the possibility that the IB b region  by itself 
regulates  low  responsiveness.  With  the  available  mouse  strains,  it  was  not 
possible to distinguish whether IC b alone or only in combination with IBb and/or 
IA d  caused  low response  to K d and D b.  But the  small  difference more  likely 
reflects differentially greater reactivity to virus-altered D. Such examples have 
been previously described for LCMV-specific activity in C3H.OH mice for Dk and 
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However, in view of the results presented in Tables IV-VII, the low respon- 
siveness of D2.GD and DBA/2 mice, as compared with other H-2 ~ strains like 
BALB/c or B10.D2, is most likely explained by the influence of genes other than 
those of the I- or other H-2-gene regions.  Different from/r-controlled immune 
responses to soluble, defined antigens,  low responsiveness to the WE strain of 
LCMV is inversely related to the infectious virus dose; high virus dose causes 
low responsiveness.  But, as for the/r-controlled  mechanisms,  low responsive- 
ness is recessive (34).  Low responsiveness in LCMV infections defined by the 
absence of detectable virus-specific cytotexic activity in spleens may be caused 
by several mechanisms. 
(a)  Immune  responsiveness  may be regulated,  in  addition  to H-2-coded Ir 
genes,  by non H-2-coded ones  (35-37).  This study gave no direct evidence for 
such an argument. 
(b)  A more likely explanation is that gene(s) mapping outside the H-2  gene 
complex control virus-growth characteristics. The low responsiveness could thus 
be only an  apparent  one and mainly due to an  ~'adsorption"  or "competition" 
phenomenon. LCMV is by itself not or only rarely cytopathogenic, and patholog- 
ical processes are thus not generally caused by the virus itself (1-3). Extensive 
viral replication during a  generalized infection could thus result in widespread 
tissue distribution of infected cells expressing LCMV-altered H-2K or D. Cyto- 
toxic T cells could thus be '~competed fo~' elsewhere in liver and other organs, or 
in spleens in mice containing  many infected cells; such a  mechanism  (2) may 
well be the basis of the high dose immune paralysis phenomenon described by 
Hotchin (1) for acute LCM. High doses of LCMV injected i.c. may fail to cause 
fatal acute LCM. The LCMV strain used for the present studies is the viscero- 
tropic WE strain,  which apparently  has less affinity to brain tissue than the 
neurotropic  Armstrong  strain  of LCMV.  WE  LCMV, however,  spreads much 
easier  in  spleen  and  liver.  I.c.  injection  of Armstrong  LCMV  (100  i.c.  LDs0) 
caused the death by classical LCM in DBA/2, as well as in BALB/c mice, while 
WE LCMV failed to do so with doses greater than 10 LDso i.c. in DBA/2 mice, 
while BALB/c mice died of LCM with the same doses. These results are further 
evidence  in  favor of the  interpretation  that  low  activity  may be a  result  of 
exhaustive recruitment  of effector T cells away from the critical target organ, 
i.e., leptomeninges and brain (2, 7). 
A  similar  non-H-2-1inked differential  capacity to deal with infectious virus 
has been found for ectromelia virus infections in mice  (R. V.  Blanden,  B. D. 
Deak, and H. O. McDevitt, unpublished). A-strain mice are much more suscep- 
tible  to  subcutaneous  ectromelia  infection  than  C57BL/10  or  C57BL/6  mice. 
However, both A  and C57BL mice generate strong ectromelia-specific in vitro 
cytotoxicity when injected i.v.  (17).  Although a  minor but significant factor of 
resistance is linked to H-2 b, non H-2 genes appear to be of greater importance in 
determining susceptibility in this model. Also susceptibility to Listeria monocy- 
togenes  infection is greater for A  than for C57BL/6 mice  (R.  M.  Zinkernagel, 
unpublished observation), suggesting a possible involvement of macrophages in 
determining this trait. 
Immune response to infectious viruses is associated predominantly with K- or 
D-coded structures,  and  no role for/-region  genes could yet be demonstrated ZINKERNAGEL,  DUNLOP,  BLANDEN,  DOHERTY,  AND  SHREFFLER  529 
regulating overall susceptibility or generation in vivo or activity in  vitro of 
effector T  cells.  The discrepancies,  with  respect to  specificity and  probably 
regulation of immune responsiveness, between infectious agents and chemically 
defined,  inert  (i.e.,  not multiplying) antigens may well reflect fundamental 
biological differences. Soluble, noninfectious, well-defined antigens will, once 
injected, not increase in quantity. It is mainly the initial amount, the degree of 
toxicity, the rate of metabolic degradation, and immune elimination of these 
antigens which determines the quantity and quality of the immune response. 
Besides Ir  genes,  status of activation of macrophages, adjuvant effects, and 
cross-reactivity of antigens are probably amongst many other things, of impor- 
tance in determining the nature of the immune response (38). 
Viruses replicate within the host and reach maximal antigenic concentrations 
(e.g., virus antigens expressed on cell surfaces) within a few days. With these 
antigens, early and mainly nonimmunological mechanisms, which may control 
spread and multiplication of infectious agents, are possibly more important than 
Ir  genes  in  determining the  outcome of the  developing protective immune 
response and the race between the damaging effect of infection, particularly in 
infections with cytopathogenic viruses. The sum of these factors sets the stage 
for the developing immune response. Immune regulatory mechanisms, like Ir 
genes,  may further determine the  response,  but  possibly  only for antibody 
production. In addition, other immunological parameters, like degree of anti- 
genic difference from host cell structures, may play a more crucial role. Viruses 
may resemble cell surface (e.g., H-2) structures and therefore escape immune 
attack by T-cell reactivity; alternatively failing to associate with K  or D  may 
result in escape from immune surveillance. 
Summary 
Lymphocytic  choriomeningitis virus (LCMV) and ectromelia virus-specific T- 
cell-mediated cytetoxicity was assayed in various strain combinations using as 
targets peritoneal macrophages which have been shown to express Ia antigens. 
Virus-specific cytotoxicity was  found only in H-2K-  or D-region compatible 
combinations./-region compatibility was not necessary nor alone sufficient for 
lysis. Six different/-region specificities had no obvious effect on the capacity to 
generate in vivo specific cytotoxicity (expressed in vitro) associated with D ~l. 
Low LCMV-specific cytotoxic activity generated in DBA/2 mice was caused by 
the non-H-2 genetic background. This trait was inversely related to the infec- 
tious virus dose and recessive. 
Non-H-2 genes, possibly involved in controlling initial spread and multiplica- 
tion of virus, seem to be,  at least in the examples tested, more important in 
determining virus-specific cytotoxic T-cell activity in spleens than are Ir genes 
coded in H-2. 
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